Xue, Weiqiao – Trademark Portfolio
Entity Type: 01
Xue, Weiqiao holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 8 (Hand Tools) — 5 filings in this category. The portfolio also extends into Class 6 (Metal Goods) across 4 Nice Classification classes. Currently, 5 trademarks are registered and 1 is pending. Notable registered marks include DEXUM, PRYLO, PRYXA, TIVEX, and TOEASYWAY. The owner is based in Shenzhen, Guangdong.
2301, Block B, Bldg. 5, Metro Jinshang
Garden,No. 1016,Longgang Ave.,Longgang,
Shenzhen, Guangdong 518100 , CN
Showing of trademarks Trademarks
Trademark Classifications
Xue, Weiqiao's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Common metals and their alloys; metal building materials; transportable buildings of metal
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Games and playthings; gymnastic and sporting articles; decorations for Christmas trees
Frequently Asked Questions
How many trademarks does Xue, Weiqiao have?
Xue, Weiqiao has 8 U.S. trademarks filed with the USPTO. Of these, 5 registered, 1 pending, 2 abandoned.
What trademark classes does Xue, Weiqiao file in?
Xue, Weiqiao files trademarks across 4 Nice Classification classes. The most active classes are Class 8 (Hand Tools), Class 6 (Metal Goods), Class 5 (Pharmaceuticals), Class 28 (Toys & Sporting Goods). Class 8 covers hand tools and implements (hand-operated); cutlery; side arms; razors.
What are Xue, Weiqiao's most well-known trademarks?
Xue, Weiqiao's registered trademark portfolio includes well-known marks such as DEXUM, PRYLO, PRYXA, TIVEX, and TOEASYWAY. These are among 5 currently registered trademarks in the portfolio.
What is Xue, Weiqiao's trademark registration success rate?
Xue, Weiqiao has a 71% trademark registration rate, with 5 out of 7 resolved applications resulting in successful registration. Currently, 1 application is pending review.